TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biovica International AB
Closing information (x1000 EUR)
| Closing information | 2024/04 (consolidated) | 2023/04 (consolidated) | 2022/04 (consolidated) |
| Turnover |
620
|
299
|
198 |
| Financial expenses |
25
|
44
|
8 |
| Earnings before taxes |
-10,562
|
-9,775
|
-5,818 |
| EBITDA |
-9,990
|
-9,030
|
-5,204 |
| Total assets |
11,181
|
15,216
|
14,706 |
| Current assets |
7,497
|
10,597
|
9,205 |
| Current liabilities |
2,407
|
2,088
|
1,561 |
| Equity capital |
8,223
|
12,244
|
12,035 |
| - share capital |
477
|
269
|
184 |
| Employees (average) |
37
|
31
|
25 |
Financial ratios
| Fiscal year | 2024/04 (consolidated) | 2023/04 (consolidated) | 2022/04 (consolidated) |
| Solvency |
73.5%
|
80.5%
|
81.8% |
| Turnover per employee |
17
|
10
|
8 |
| Profit as a percentage of turnover |
-1703.5%
|
-3269.2%
|
-2938.4% |
| Return on assets (ROA) |
-94.2%
|
-64.0%
|
-39.5% |
| Current ratio |
311.5%
|
507.5%
|
589.7% |
| Return on equity (ROE) |
-128.4%
|
-79.8%
|
-48.3% |
| Change turnover |
332
|
118
|
-3 |
| Change turnover % |
115%
|
65%
|
-2% |
| Chg. No. of employees |
6
|
6
|
5 |
| Chg. No. of employees % |
19%
|
24%
|
25% |
Total value of public sale
| Fiscal year | 2024/04 (consolidated) | 2023/04 (consolidated) | 2022/04 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.